Lv4
502 积分 2025-03-25 加入
Deulorlatinib (TGRX-326) in ALK Gene Fusion Positive NSCLC After Failure of Second-Generation Inhibitors: A Single-Arm, Multicenter, Phase 2 Trial
14小时前
待确认
Chinese consensus on the diagnosis and management of herpes zoster （2022）
13天前
已完结
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas
19天前
已完结
Practical Aspects of Delivering Radiation for Polymetastatic Disease
26天前
已完结
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial
26天前
已完结
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
27天前
已完结
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
1个月前
已完结
Dose constraints in breast cancer radiotherapy. A critical review
1个月前
已完结
LITE SABR M1: A phase I trial of Lattice stereotactic body radiotherapy for large tumors
2个月前
已完结
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
3个月前
已完结
皖公网安备34019202002308
